Section 3A Cost-effectiveness analysis

Page last updated: September 2016

Section 3A provides information requests for preparing a full CEA.

The PBAC prefers that the economic evaluation is based on results from direct randomised trials (see Section 2), with any adjustments or additions to the trial data to account for differences in the population and setting, timeframe of analysis or outcomes of interest presented transparently in a stepped manner. For economic evaluations that rely on results from indirect comparisons of randomised trials or comparisons based on nonrandomised studies, an adaptation of the stepped approach is recommended.

Flowchart 3A.1 shows the key flow of information in Section 3 when there is a superior or inferior therapeutic conclusion leading to a full cost-effectiveness analysis.

Flowchart 3A.1 Overview of information requests for Section 3A of a submission to the PBAC based on a full cost-effectiveness analysis